Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase NA 2Phase 1/2 1

Status

Terminated 4Completed 2Unknown 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Neutropenia 1Neoplasms 1Infections 1Fever 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 49Radiotherapy 47Docetaxel 42Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Imatinib Mesylate 14Drug Therapy 14Irinotecan 13Filgrastim 13Zoledronic Acid 12Trastuzumab 12Radiosurgery 12Erlotinib Hydrochloride 12Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Ciprofloxacin × Clear all
NCT03862170 2025-02-12

BRP30

CR-CSSS Champlain-Charles-Le Moyne

Phase 3 Terminated
158 enrolled
Genitourinary

Prostatic Neoplasms

NCT00107081 2020-11-02

Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Swiss Pediatric Oncology Group

Phase 3 Terminated
70 enrolled

Fever, Neoplasms, Neutropenia

NCT00003824 2012-03-09

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

SWOG Cancer Research Network

Phase 3 Terminated
114 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00294749 2009-01-27

Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy

Poitiers University Hospital

Phase 3 Terminated
300 enrolled

Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡